Feb 16, 2026 · 44m · paul-morris
Chasing Wealth, Neglecting Health — The Real Consequences.
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
Host Paul Morris and regenerative medicine physician Dr. Jonas Kuno explore the vital connection between wealth and health, highlighting how metabolic optimization, proactive therapies, and patient self-advocacy can overcome the limitations of conventional medicine.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. How this is scored →
Paul as informed peer 3.8 Guest teaching 4.3 Guest disagreement 1.1 Paul pushing back 1.3
speaking balance: gold is Paul, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 6:12 Dr. Kuno directly challenges the host's interpretation of PSA advice
Dr. Kuno explicitly reframes Morris's premise that his urologist was telling him to wait for cancer, clarifying that PSA is a crude marker and not a direct cancer diagnosis.
Hardest push from Paul ▶ 7:52 Morris refuses the conventional framing and reiterates lack of preventative careMorris insists on holding his position regardless of PSA technicalities, emphasizing that standard medicine offered zero proactive prevention.
Biggest teaching moment ▶ 26:20 Dr. Kuno explains mitochondrial melatonin production and near-infrared lightDr. Kuno educates Morris on how cellular melatonin is generated primarily inside mitochondria via near-infrared radiation to neutralize metabolic free radicals.
Paul holds their own ▶ 35:50 Morris calculates all-cause mortality impact using Peter Attia's frameworkMorris showcases thorough analytical preparation by breaking down population demographics and indolent rates to deduce why prostate cancer eradication yields only a 1% drop in all-cause mortality.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Paul as informed peer | Guest teaching | Guest disagreement | Paul pushing back | Why |
|---|---|---|---|---|---|---|
| From Traditional Geriatric Care to Cryotherapy and Regenerative Medicine | 3 | 4 | 1 | 0 | Morris introduces the connection between financial stress and physical health, while Dr. Kuno details his background moving from geriatric polypharmacy to cryotherapy. Dr. Kuno explains the role of microinflammatory environments in chronic disease and cancer, which the host readily accepts. | |
| Prostate Cancer Surveillance, PSA Limitations, and Preventative Healthcare | 4 | 5 | 2 | 4 | Morris shares his frustration with conventional urology telling him to retest his PSA in six months rather than offering preventative action. Dr. Kuno gently corrects his premise by clarifying that PSA is merely a crude indicator of prostate tissue changes rather than definitive cancer. Morris pushes back to reassert that standard care still failed to offer proactive lifestyle interventions. | |
| Financial Biases, Repurposed Generic Drugs, and the Metabolic Theory of Cancer | 5 | 6 | 2 | 1 | The dialogue explores financial hurdles in studying off-patent repurposed therapeutics like low-dose naltrexone and ivermectin, alongside the metabolic theory of cancer. Morris demonstrates solid grasp of FDA safety-versus-efficacy hurdles and dosing math. Dr. Kuno delivers a technical explanation of mitochondrial fermentation, the citric acid cycle, and glutamine utilization in cancer cells. | |
| Evaluating Dietary Supplements, Quality Control, and AI-Driven Self-Advocacy | 4 | 4 | 1 | 1 | Morris describes his strategy of using AI to cross-reference dietary supplements and identify reputable brands. Dr. Kuno outlines the structural pitfalls of supplement manufacturing, emphasizing the necessity of third-party testing and certificates of analysis. | |
| Regenerative Therapies: Cryotherapy, Photobiomodulation, and Stem Cells | 3 | 7 | 0 | 0 | Dr. Kuno delivers comprehensive clinical overviews of cryotherapy cytokine regulation, near-infrared photobiomodulation of mitochondrial melatonin, and umbilical cord stem cell therapy. Morris listens attentively, providing brief validation and personal anecdotes. | |
| Navigating Gaps in Primary Care and the Imperative of Patient Self-Advocacy | 4 | 3 | 1 | 1 | The conversation examines systemic time pressures on primary care physicians and the growing necessity for patients to use AI tools for self-advocacy. Morris draws an informed parallel between medical school constraints and his own training in law and business school. | |
| All-Cause Mortality, Metabolic Syndrome, and Sustainable Weight Loss Protocols | 6 | 5 | 2 | 3 | Morris discusses Peter Attia's all-cause mortality framework, breaking down the statistical risk contribution of prostate cancer versus metabolic syndrome. Dr. Kuno advocates for high-protein early eating windows, while Morris pushes back with his personal experience of sustained 22-hour fasting being easier to maintain than mid-day meals. | |
| Rapid-Fire Questions, Personal Philosophy, and Interview Conclusion | 1 | 0 | 0 | 0 | Morris conducts a structured Proust-style rapid-fire questionnaire exploring Dr. Kuno's personal values, greatest achievements, and motivations. The exchange concludes on an affectionate and collaborative note. |
Statements from this episode (15)
Kuno: Americans Over 70 Take an Average of 20 Medications
“Interestingly in the U S here, when you're over the age of 70, you have about 20 medications.”
Dr. Jonas Kuno: Cryotherapy Effectively Treats Autoimmune and Inflammatory Disorders
“Anti-inflammatory treatments, essentially for not just for athletes, but also for the general population for all sorts of things originally for rheumatoid arthritis. That's what it was developed for. Sports injuries, certainly, and any inflammatory disorder, a…”
Dr. Jonas Kuno: Low-dose naltrexone improves cancer outcomes by reducing inflammation
“One of the latest things in cancer research, which was interesting, there is a Microinflammatory environment that cancer cells need to thrive. They don't need oxygen. They like a low oxygen environment and they like an inflammatory environment. And so they're …”
Dr. Jonas Kuno: PSA Is an Imprecise Marker, Not Definitive Cancer Diagnosis
“The PSA, the prostate-specific antigen is a very crude marker. It doesn't tell you if you have cancer or not. It's, it says the likelihood is higher if we cross that four four point or mark, right? But you know, again, even benign prosthetic hypertrophy, you w…”
Dr. Jonas Kuno: Finasteride Blocks DHT to Reduce Hair Loss and Prostate Growth
“Finasteride is something that can, Prevent the conversion of testosterone to dihydrotestosterone, DHT. And DHT is, one, it's bad for the half follicle, but can also cause prosthetic growth.”
Dr. Kuno: Preclinical Studies Show Ivermectin Triggers Cancer Cell Apoptosis
“There's a combination of what is it? Mabendazole and ivermectin, for example. Couldn't say that word like three years ago, you know, but again, this was something that predates COVID. It's been studied to treat cancer. Has some good mechanism where triggers ap…”
Dr. Kuno: Cancer Cells Rely on Fermentation Due to Mitochondrial Dysfunction
“And when you look at cancer cells, they have malfunctioning mitochondria. The mitochondria can't do this elaborate Citric acid cycle where they take sugar and makes 36 ATP per molecule. They can only ferment. It's a very primitive way of energy production, two…”
Kuno: Cryotherapy enables rheumatoid arthritis patients to stop immunosuppressive drugs
“So we have people as an example with rheumatoid arthritis, and many of them were on immunosuppressive agents. You've heard about Humira and all these advertised, right? They bring your immune system down to manage the overreaction that causes this joint proble…”
Kuno: About 54% of sunlight is near-infrared radiation
“54% of sunlight is near infrared radiation.”
Kuno: 95% of human melatonin is produced in mitochondria
“95% of melatonin is made in our mitochondria, and it's an anti-inflammatory.”
Kuno: Umbilical cord stem cells recognize cancer cells and trigger apoptosis
“Umbilical cord stem cells are from newborns, from healthy c-section births. It's the birth tissue that usually gets discarded. Now, these cells don't have a fingerprint. They become your own cells to some extent, but they also recognize cancer cells, and they …”
Morris: Curing prostate cancer would lower all-cause mortality by 1%
“Curing prostate cancer would lower all cause mortality by one percent.”